Hodges Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Hodges Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,000	Closed	-$1.97M	–	251
2018 Q1	$1.97M	Buy	+1,000	New	+$77.3K	0.16%	118
2015 Q2	–	Sell	-25,000	Closed	-$2.36M	–	292
2015 Q1	$2.36M	Sell	25,000 -65,000	-72%	-$7.28M	0.09%	135
2014 Q4	$10.1M	Sell	90,000 -40,000	-31%	-$3.57M	0.41%	89
2014 Q3	$7.97M	Buy	+130,000	New	+$5.6M	0.33%	111

Other funds holding AGIO

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

ClearBridge Investments

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return